FENC
Fennec Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.39
−1.27%Margins
Gross margin
93.7%
EBITDA margin
-4.0%
EBIT margin
-2.0%
Net margin
-5.5%
FCF margin
-3.4%
-7.7%
Return on equity
-4.3%
Return on assets
-2.7%
Return on invested capital
0.80x
Asset turnover
-$2.0M
Cash from operations
$1.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026